Whilst wild-type p53 expression is associated with decreased proliferation due to inhibition of cyclin-dependent kinases, overexpression of regulatory mechanisms such as MDM2 control p53-dependent growth in glioma (Reifenberger et al., 1993; Suh et al., 2012). Here, TP53 is linked to glioma.